NP / PA
Weibley, Christina
Weibley, Christina was paid $258K by Medicaid between Aug 2023 and Dec 2024, across 26 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoWEIBLEY, CHRISTINA
SHILOH, IL 62269
SHILOH, IL 62269
33aNPI1043941123assigned 06/21/2022
33bProvider typeNurse Practitioner
28Total paid$258K
24GClaims7,105
24DCodes billed26
24AFirst – last monthAug 2023 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#112 of 1,687
Median peer was paid$22K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 851 | $30K | |
| 2024incomplete | 6,254 | $227K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 1,244 | 1,048 | $88K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 730 | 601 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11% | 728 | 602 | $28K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 8.9% | 461 | 385 | $23K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 7.3% | 671 | 549 | $19K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.1% | 211 | 170 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.3% | 121 | 80 | $11K |
| 86780 | 2.8% | 477 | 385 | $7K | |
| 86803 | 2.5% | 412 | 330 | $6K | |
| 96127 | 2.2% | 391 | 301 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.9% | 116 | 87 | $5K |
| 87340 | 1.8% | 387 | 315 | $5K |
14 more codes
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.6% | 72 | $4K |
| 81025 | <1% | 380 | $2K | |
| 87511 | <1% | 45 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 281 | $2K |
| 99459 | <1% | 92 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 37 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 92 | $884.00 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 16 | $812.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 64 | $405.10 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 18 | $311.71 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16 | $260.58 |
| 96160 | <1% | 15 | $219.00 | |
| 86762 | <1% | 15 | $139.54 | |
| 82950 | <1% | 13 | $60.58 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.